Roche to acquire Santaris Pharma for $450 million
Swiss pharmaceutical giant Roche says it plans to buy Denmark-based biotech company Santaris Pharma for up to $450 million, Reuters reported on August 4. According to the report, Roche announced it would pay Santaris Pharma an initial amou…
Read MoreWritten by James H. Arenson
Last Updated : August 18, 2014